Cargando…
Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents
BACKGROUND: Endoscopic submucosal dissection (ESD) has become widely accepted as a standard treatment for gastric epithelial neoplasms. Antithrombotic agents are widely used to prevent thromboembolic disease. However, the feasibility of endoscopic procedures for patients using such agents has been r...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287424/ https://www.ncbi.nlm.nih.gov/pubmed/25280756 http://dx.doi.org/10.1186/1471-230X-14-172 |
_version_ | 1782351782833291264 |
---|---|
author | Matsumura, Tomoaki Arai, Makoto Maruoka, Daisuke Okimoto, Kenichiro Minemura, Shoko Ishigami, Hideaki Saito, Keiko Nakagawa, Tomoo Katsuno, Tatsuro Yokosuka, Osamu |
author_facet | Matsumura, Tomoaki Arai, Makoto Maruoka, Daisuke Okimoto, Kenichiro Minemura, Shoko Ishigami, Hideaki Saito, Keiko Nakagawa, Tomoo Katsuno, Tatsuro Yokosuka, Osamu |
author_sort | Matsumura, Tomoaki |
collection | PubMed |
description | BACKGROUND: Endoscopic submucosal dissection (ESD) has become widely accepted as a standard treatment for gastric epithelial neoplasms. Antithrombotic agents are widely used to prevent thromboembolic disease. However, the feasibility of endoscopic procedures for patients using such agents has been rarely investigated. The aim of this study was to identify risk factors for post-operative bleeding after gastric ESD and to evaluate the relationship between the use of antithrombotic agents and post-operative bleeding. METHODS: From June 2005 to March 2014, 413 patients with 425 gastric neoplasms were treated by ESD. The demographic and clinical parameters associated with post-operative bleeding were investigated. 83 patients receiving antithrombotic agents were separately assessed using various methods of administration during the ESD procedure. Post-operative bleeding that occurred within 5 days of ESD was defined as early post-operative bleeding, whereas subsequent bleeding was defined as delayed bleeding. RESULTS: The overall post-operative bleeding rate was 4.7%. In patients with continued low-dose aspirin (LDA), heparin replacement (HR), or continued LDA along with HR, post-operative bleeding rates were 9.5%, 23.8%, and 25.0%, respectively. On multivariate analysis, a specimen size of ≥40 mm was a risk factor for early post-operative bleeding [odds ratio (OR) 6.08, 95% CI: 1.74–21.27], and HR and chronic kidney disease (CKD) requiring hemodialysis were risk factors for delayed bleeding (OR 12.23, 95% CI: 2.63–56.77 and OR 28.35, 95% CI: 4.67–172.11, respectively). Continued LDA was not a risk factor for post-operative bleeding. CONCLUSIONS: Large specimen size is a risk factor for early post-operative bleeding, and HR and CKD requiring hemodialysis are risk factors for delayed bleeding. Patients with risk factors should be carefully watched, allowing for the timing of post-operative bleeding after ESD. |
format | Online Article Text |
id | pubmed-4287424 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42874242015-01-09 Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents Matsumura, Tomoaki Arai, Makoto Maruoka, Daisuke Okimoto, Kenichiro Minemura, Shoko Ishigami, Hideaki Saito, Keiko Nakagawa, Tomoo Katsuno, Tatsuro Yokosuka, Osamu BMC Gastroenterol Research Article BACKGROUND: Endoscopic submucosal dissection (ESD) has become widely accepted as a standard treatment for gastric epithelial neoplasms. Antithrombotic agents are widely used to prevent thromboembolic disease. However, the feasibility of endoscopic procedures for patients using such agents has been rarely investigated. The aim of this study was to identify risk factors for post-operative bleeding after gastric ESD and to evaluate the relationship between the use of antithrombotic agents and post-operative bleeding. METHODS: From June 2005 to March 2014, 413 patients with 425 gastric neoplasms were treated by ESD. The demographic and clinical parameters associated with post-operative bleeding were investigated. 83 patients receiving antithrombotic agents were separately assessed using various methods of administration during the ESD procedure. Post-operative bleeding that occurred within 5 days of ESD was defined as early post-operative bleeding, whereas subsequent bleeding was defined as delayed bleeding. RESULTS: The overall post-operative bleeding rate was 4.7%. In patients with continued low-dose aspirin (LDA), heparin replacement (HR), or continued LDA along with HR, post-operative bleeding rates were 9.5%, 23.8%, and 25.0%, respectively. On multivariate analysis, a specimen size of ≥40 mm was a risk factor for early post-operative bleeding [odds ratio (OR) 6.08, 95% CI: 1.74–21.27], and HR and chronic kidney disease (CKD) requiring hemodialysis were risk factors for delayed bleeding (OR 12.23, 95% CI: 2.63–56.77 and OR 28.35, 95% CI: 4.67–172.11, respectively). Continued LDA was not a risk factor for post-operative bleeding. CONCLUSIONS: Large specimen size is a risk factor for early post-operative bleeding, and HR and CKD requiring hemodialysis are risk factors for delayed bleeding. Patients with risk factors should be carefully watched, allowing for the timing of post-operative bleeding after ESD. BioMed Central 2014-10-03 /pmc/articles/PMC4287424/ /pubmed/25280756 http://dx.doi.org/10.1186/1471-230X-14-172 Text en © Matsumura et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Matsumura, Tomoaki Arai, Makoto Maruoka, Daisuke Okimoto, Kenichiro Minemura, Shoko Ishigami, Hideaki Saito, Keiko Nakagawa, Tomoo Katsuno, Tatsuro Yokosuka, Osamu Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents |
title | Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents |
title_full | Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents |
title_fullStr | Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents |
title_full_unstemmed | Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents |
title_short | Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents |
title_sort | risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287424/ https://www.ncbi.nlm.nih.gov/pubmed/25280756 http://dx.doi.org/10.1186/1471-230X-14-172 |
work_keys_str_mv | AT matsumuratomoaki riskfactorsforearlyanddelayedpostoperativebleedingafterendoscopicsubmucosaldissectionofgastricneoplasmsincludingpatientswithcontinueduseofantithromboticagents AT araimakoto riskfactorsforearlyanddelayedpostoperativebleedingafterendoscopicsubmucosaldissectionofgastricneoplasmsincludingpatientswithcontinueduseofantithromboticagents AT maruokadaisuke riskfactorsforearlyanddelayedpostoperativebleedingafterendoscopicsubmucosaldissectionofgastricneoplasmsincludingpatientswithcontinueduseofantithromboticagents AT okimotokenichiro riskfactorsforearlyanddelayedpostoperativebleedingafterendoscopicsubmucosaldissectionofgastricneoplasmsincludingpatientswithcontinueduseofantithromboticagents AT minemurashoko riskfactorsforearlyanddelayedpostoperativebleedingafterendoscopicsubmucosaldissectionofgastricneoplasmsincludingpatientswithcontinueduseofantithromboticagents AT ishigamihideaki riskfactorsforearlyanddelayedpostoperativebleedingafterendoscopicsubmucosaldissectionofgastricneoplasmsincludingpatientswithcontinueduseofantithromboticagents AT saitokeiko riskfactorsforearlyanddelayedpostoperativebleedingafterendoscopicsubmucosaldissectionofgastricneoplasmsincludingpatientswithcontinueduseofantithromboticagents AT nakagawatomoo riskfactorsforearlyanddelayedpostoperativebleedingafterendoscopicsubmucosaldissectionofgastricneoplasmsincludingpatientswithcontinueduseofantithromboticagents AT katsunotatsuro riskfactorsforearlyanddelayedpostoperativebleedingafterendoscopicsubmucosaldissectionofgastricneoplasmsincludingpatientswithcontinueduseofantithromboticagents AT yokosukaosamu riskfactorsforearlyanddelayedpostoperativebleedingafterendoscopicsubmucosaldissectionofgastricneoplasmsincludingpatientswithcontinueduseofantithromboticagents |